| Literature DB >> 28472924 |
Rune Andreassen1, Nardos Tesfaye Woldemariam2, Ine Østråt Egeland2, Oleg Agafonov3, Hilde Sindre4, Bjørn Høyheim5.
Abstract
BACKGROUND: MicroRNAs (miRNAs) control multiple biological processes including the innate immune responses by negative post-transcriptional regulation of gene expression. As there were no studies on the role(s) of miRNAs in viral diseases in Atlantic salmon, we aimed to identify miRNAs responding to salmonid alphavirus (SAV) infection. Their expression were studied at different time points post infection with SAV isolates associated with different mortalities. Furthermore, the genome sequences of the identified miRNAs were analysed to reveal putative cis-regulatory elements, and, finally, their putative target genes were predicted.Entities:
Keywords: Atlantic salmon; Innate immune response; Virus; miRNA
Mesh:
Substances:
Year: 2017 PMID: 28472924 PMCID: PMC5418855 DOI: 10.1186/s12864-017-3741-3
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Shows the increase in viral loads assessed by RT-qPCR. The mean Ct-values are given for each of the three groups challenged with SAV2-i1 (blue), SAV3-i4 (dark orange) or SAV3-i6 (green) at week 1–4 poc. The controls are the SAV negative healthy fish sampled at the initiation of the challenge trial (Ct values > 45). At week 1 poc all samples were SAV negative. At week 2 poc the plot show results from only those samples that were SAV positive. All fish sampled at week 3 and 4 poc were SAV positive
DE miRNAs revealed by DESeq2 and RT-qPCR analysis in SAV3-i4 infected individuals at week 4 poc
| Mature miRNA | SAV expression1 | log2 fold change2 | DESeq2 P-adj.3 | log2 f.c. RT-qPCR4 | RT-qPCR P-adj.5 | Family6 |
|---|---|---|---|---|---|---|
| ssa-miR-462a-5p | increase 13x | 3.71 | 1.93x10-5 | 2.58 | 3.0x10-3 | 462 |
| ssa-miR-462a-3p | increase 19x | 4.30 | 2.41x10-5 | 3.12 | 3.0x10-3 | 462 |
| ssa-miR-462b-5p | increase 3x | 1.75 | 0.07 | − | − | 462 |
| ssa-miR-731-5p | increase 12x | 3.58 | 1.79x10-3 | 2.63 | 3.0x10-3 | 731 |
| ssa-miR-731-3p | increase 8x | 3.04 | 1.64x10-3 | 2.28 | 3.0x10-3 | 731 |
| ssa-miR-146b-5p | increase 14x | 3.82 | 1.17x10-4 | 2.38 | 3.0x10-3 | 146 |
| ssa-miR-146a-3p | increase 6x | 2.64 | 0.03 | 2.99 | 3.0x10-3 | 146 |
| ssa-miR-146a-3-3p | increase 8x | 3.00 | 0.03 | − | − | 146 |
| ssa-miR-21a-1-3p | increase 10x | 3.27 | 4.3x10-3 | 3.31 | 3.0x10-3 | 21 |
| ssa-miR-21a-2-3p | increase 8x | 3.16 | 0.02 | 2.21 | 3.0x10-3 | 21 |
| ssa-miR-21b-3p | increase 5x | 2.36 | 0.06 | 2.33 | 3.0x10-3 | 21 |
| ssa-miR-181c-5p | increase 4x | 2.14 | 0.09 | 1.42 | 0.011 | 181 |
| ssa-miR-223-5p | increase 5x | 2.36 | 0.06 | 2.46 | 3.0x10-3 | 223 |
| ssa-miR-1338-3p | increase 3x | 1.65 | 0.06 | 1.61 | 3.0x10-3 | 1338 (1388) |
| ssa-miR-155-5p | increase 3x | 1.72 | 0.06 | 0.58 | 0.1 | 155 |
| ssa-miR-92a-3-5p3 | increase 10x | 3.4 | 0.06 | − | − | 92 |
| ssa-miR-7132-3p | increase 3x | 1.79 | 0.06 | 1.88 | 3.0x10-3 | 7132 |
| ssa-miR-7132-5p | increase 4x | 2.11 | 0.07 | 1.06 | 0.02 | 7132 |
| ssa-miR-734-3p | decrease 4x | -2.09 | 0.07 | -0.19 | 0.96 | 734 |
| ssa-miR-2188-3p | decrease 2x | -1.08 | 0.10 | -0.95 | 3.0x10-3 | 2188 |
1Direction and approximate relative change (times fold change) of mature miRNAs in SAV infected tisssues from DESeq2 measurements
2Log2 fold change from DESeq2 analysis of deep sequencing samples
3Adjusted p-values from DESeq2 analysis. 0.1 was used as threshold for significance
4Log2 fold change (∆∆Ct-method) from RT-qPCR analysis
5 P-values from RT-qPCR after adjustment according to Benjamini-Hochberg procedure. 0.05 was used as threshold for significance
6Those with identical numbers belong to same miRNA gene family or are corresponding 5p and 3p from same miRNA gene
Fig. 2Shows the relative change in the 17 miRNAs initially detected by DESeq2 analysis and subsequently analysed by RT-qPCR. The blue bars indicate the log2 fold changes from DESeq2 analysis. The red bars indicate the log2 fold changes from RT-qPCR analysis. Results from DESeq2 and RT-qPCR for same miRNA are grouped together. Below the figure is a table with log2 fold changes given for each of the miRNAs from both DESeq2 and RT-qPCR analysis
Fig. 3Shows the relative changes in miRNA expression at all time points for each of the SAV groups for the following miRNAs: ssa-miR-462a-5p, ssa-miR-731-5p, ssa-miR-146a-3p, ssa-miR-146b-5p, ssa-miR-223-5p, ssa-miR-181c-5p, ssa-miR-155-5p and ssa-miR-7132-3p. The corresponding mature miRNAs from the miRNA gene cluster miRNA-462/731 (ssa-miR-462a-3p and ssa-miR-731-3p) showed very similar results, and for simplicity reasons these are not given in the figure, but in Additional file 3
Fig. 4Shows the relative changes in expression for ssa-miR-21a-1-3p, ssa-miR-21b-3p, ssa-miR-21a-2-3p, ssa-miR-1338-3p, ssa-miR-7132-5p and ssa-miR-2188-3p at all time points for each of the SAV groups
Results from prediction of target genes among a set of SAV responsive immune network genes
| Gene | Gene function/relevance to SAV infection1 | Predicted by four search tools2 | Predicted by three search tools3 | Reference4 |
|---|---|---|---|---|
| Neutrophil cytosolic factor 1 | inflammatory response, superoxide anion and cell death, increased expression in SAV | miR-92a-3-5p, miR-181c-5p | miR-146a-3-3p, miR-146a-3p, miR-155-5p | Johansen et al., [ |
| VHSV inducible like protein (VIG-B319) | virus responsive, increased expression in VHSV and SAV | miR-155-5p, miR-223-5p | miR-146b-5p, miR-1338-3p | Johansen et al., [ |
| Jeltraxin | similar to CRP, innate immunity pathway, increased expression in SAV | miR-146b-5p | miR-181c-5p | Johansen et al., [ |
| Interferon-inducible protein Gig2-7-like | virus responsive, increased expression in SAV | − | miR-462a-3p | Johansen et al., [ |
| Nuclear factor of kappa light polypept gene enhancer in B-cells 2 (NFkB2) | miR-223 target in other vertebrate, innate immune system, inflammatory response | miR-462a-3p | miR-146b-5p | Aziz et al., [ |
| Myeloperoxidase | promote inflammation, innate immunity pathway, increased expression in SAV | miR-462a-3p, miR-146b-5p | miR-223-5p, miR-734-3p, miR-2188-3p | Johansen et al., [ |
| Macrosialin precursor CD68 | virus responsive, increased expression in SAV | miR-462a-3p, miR-731-5p | miR-181c-5p | Johansen et al., [ |
| ATP-dependent RNA helicase DHX58 (RIG-I-like 3) | virus responsive, innate immunity pathway, increased expression in SAV | − | miR-731-5p | Johansen et al., [ |
| Interferon regulatory factor 7 (IRF7) | transcription factor activating innate immunity pathway, increased expression in SAV | miR-731-5p | − | Xu et al., [ |
| Interferon regulatory factor 3 (IRF3) | transcription factor activating innate immunity pathway, increased expression in SAV | miR-21a-2-3p, miR-21b-3p | miR-181c-5p, miR-734-3p | Xu et al., [ |
| C–C motif chemokine 19 | inflammatory response, innate immunity pathway, increased expression in SAV | − | miR-731-3p, miR-223-5p, miR-1338-3p | Johansen et al., [ |
| Interferon-inducible protein Gig2-2-like | virus responsive, increased expression in SAV | miR-181c-5p | − | Johansen et al., [ |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha-like (IKKa) | miR-223 target in other vertebrate, innate immune system and inflammatory response | miR-181c-5p (multiple sites) | miR-223-5p, miR-7132-5p, miR-1338-3p, miR-734-3p | Aziz et al., [ |
| Cholesterol 25-hydroxylase-like protein A | virus responsive, innate immunity pathway, increased expression in SAV | miR-181c-5p | − | Johansen et al., [ |
| Complement factor D (CFAD) | inflammatory response, innate immunity pathway, upregulated in SAV | − | miR-223-5p | Johansen et al., [ |
| Interleukin-10 receptor beta chain precursor | Cytokine-mediated signaling pathway, immune response, upregulated in SAV | − | miR-21a-2-3p, miR-146a-3-3p, miR-146a-3p, miR-223-5p | Johansen et al., [ |
| SOCS1 | antiviral innate immune response | − | miR-223-5p | Taganov et al., [ |
| Fish virus induced TRIM-3 | Virus responsive, antiviral innate immunity, upregulated in SAV | − | miR-181c-5p | Johansen et al., [ |
| Forkhead box protein O1-A-like (FOXO1) | miR-223 target in other vertebrate, immune system signaling pathways, promote cell death | − | miR-2188-3p | Aziz et al., [ |
| Complement C1qB subcomponent | inflammatory response, innate immunity pathway, increased expression in SAV | − | miR-21a-1-3p, miR-223-5p, miR-2188-3p (multiple sites) | Johansen et al., [ |
| Barrier-to-autointegration factor | known to be exploited by retrovirus, increased expression in SAV | − | miR-21a-2-3p, miR-21b-3p | Johansen et al., [ |
| Viperine (RSAD2) | virus responsive, innate immunity antiviral, increased expression in SAV | − | miR-223-5p, miR-734-3p | Johansen et al., [ |
| Interferon gamma 1 | virus responsive, cytokine | − | miR-734-3p | Sun et al., [ |
| Interferon gamma 2 | virus responsive, cytokine | − | miR-734-3p | Sun et al., [ |
1Key words about gene function are based on gene function description in the http://www.uniprot.org/uniprot/ database. 2DE-miRs predicted to target the gene by all the four target search tools used (RNA-hybrid, TargetSpy, PITA, Miranda)
3DE-miRs predicted to target the gene by three of the four target search tools used. 4Relevance to SAV is based on findings in the references given in this column
Predicted target genes with immune response related function from in silico analysis using the Atlantic salmon transcriptome as input (holistic apporach)
| Gene | Gene function1 | Predicted by four search tools2 | Predicted by three search tools3 | Reference4 |
|---|---|---|---|---|
| Interferon regulatory factor 2-binding protein 2-A | Repressor, regulation of transcription, represses the NFAT1-dependent transactivation of NFAT-responsive promoters | miR-223_5p | − | NM_001139853.1 |
| interferon regulatory factor 5 (IRF5) | Transcription factor activator that promote inflammation, innate immune system, Antiviral defense | miR-181c-5p | miR-462a-3p | NM_001139852.1 |
| CD226 antigen precursor | Activator, Receptor involved in cytokine production, regulation of immune response in innate immune system | miR-146a-3p, miR-181c-5p | miR-7132-3p | NM_001139914.1 |
| POU domain class 2-associating factor 1 | Transcriptional coactivator, humoral immune response | miR-181c-5p | − | NM_001140075.1 |
| Suppressor of IKK-epsilon | inhibitory role in virus- and TLR3-triggered IRF3, Inhibits TLR3-mediated activation of interferon-stim. response elements (ISRE) | miR-146a-3-3p, miR-146a-3p | miR-21a-2-3p, miR-21b-3p | NM_001140308.1 |
| NF-kappa-B inhibitor epsilon | Inhibition of NFkB, innate immune system signaling pathway | miR-181c-5p | miR-146b-5p | NM_001140380.1 |
| Interferon-induced protein 44 (IFI44) | GTP binding, antiviral defense | miR-21b-3p | miR-21a-2-3p | NM_001140400.1 |
| C-C chemokine receptor type 9 | Transcription coactivator binding, chemokine receptor activity, immune response | − | miR-181c-5p, miR-731-5p | NM_001140518.1 |
| C-C motif chemokine 25 precursor | Effector, chemokine-mediated signaling pathway, immune response, inflammatory response | miR-155-5p | − | NM_001140865.1 |
| C-X-C motif chemokine 10 precursor | Chemokine-mediated signaling pathway, effector, immune response, inflammatory response | miR-181c-5p | :miR-21b-3p | NM_001141028.1 |
| Interleukin-20 receptor alpha chain precursor | Activator, cytokine-mediated signaling pathway, Interleukin 20 binding, immune system | − | miR-92a-3-5p | NM_001141080.1 |
| C-C motif chemokine 21 precursor | Chemokine-mediated signaling pathway, effector, immune response, inflammatory response | miR-92a-3-5p | miR-21a-2-3p, miR-21b-3p | NM_001141267.2 |
| interferon-induced, ds RNA-activated protein kinase | Activator and effector, Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation | miR-146b-5p | − | NM_001141332.2 |
| C-C chemokine receptor type 3 | Effector, chemokine receptor activity, inflammatory response, Host-virus interaction, cellular defense response | − | miR-7132-3p | NM_001173762.1 |
| Interleukin-31 receptor A precursor | Transcription coactivator, activates STAT3, cytokine receptor activity, acute inflammatory response to antigenic stimulus | − | miR-1338-3p | NM_001173970.1 |
| interferon regulatory factor 1 (IRF1) isoform 2 | Activator, promote antiviral innate immunity response, Transcription regulation | miR-462b-5p | miR-7132-5p | NM_001252364.1 |
| interleukin 1 receptor accessory protein precursor | Activator, IL-1 signaling pathway, Immunity, Inflammatory response, innate immune response | miR-2188-3p | − | NM_001123552.1 |
| CCL4-like chemokine precursor | Effector, chemokine-mediated signaling pathway, immune response, inflammatory response | miR-146a-3-3p, miR-146a-3p | − | NM_001123618.1 |
| C-C chemokine receptor type 6 | C-C chemokine binding, cellular defense response, innate immune response | miR-181c-5p | − | NM_001139972.1 |
| Interferon regulatory factor 4 (IRF4) | Transcriptional activator, type I interferon signaling pathway, binds to ISRE, immune system pathways | − | miR-731-5p | NM_001139982.1 |
| Interleukin-13 receptor alpha-2 chain precursor | Cytokine receptor activity, immunoglobulin mediated immune response, negative regulation of immunoglobulin production | miR-731-3p | miR-731-5p | NM_001140169.1 |
| C-X-C chemokine receptor type 3 | Receptor for C-X-R chemokines, regulates biological processes such as inflammation, immunity, and would healing | miR-731-5p | miR-734-3p | NM_001140493.1 |
| nuclear factor NF-kappa-B p100 subunit | Activator and repressor, transcr. factor activity, NF-kappaB signaling pathway, innate immune response, innflammatory response | − | miR-462a-3p | NM_001173583.1 |
| toll-like leucine-rich repeat precursor | Activator, Immunity, Inflammatory response, Innate immunity | miR-731-5p | miR-2188-3p | NM_001123691.1 |
| Macrophage migration inhibitory factor (MIF) | Inhibitor/surpressor, Inflammatory response, innate immune response, cell-mediated immunity | miR-155-5p | − | NM_001141547.1 |
| BCL2/adenovirus E1B interacting protein 3-like | Effector, negative regulation of apoptotic process, Host-virus interaction, defense response to virus | miR-1338-3p, miR-146b-5p, miR-181c-5p, miR-731-5p | − | NM_001141679.1 |
| TRAF2-binding protein | mediates the IRAK1 and TRAF6 interaction following IL-1 stimulation, I-kappaB kinase/NF-kappaB signaling | − | miR-462a-3p | NM_001173784.1 |
| single Ig IL-1-related receptor precursor | Acute-phase response, neg. reg. of cytokine-mediated signaling pathway, neg. reg.of sequence-specific DNA binding transcription factor activity | miR-181c-5p, miR-462a-3p | − | NM_001173838.1 |
1Key words about gene function are based on gene function description in the http://www.uniprot.org/uniprot/ database. 2DE-miRs predicted to target the gene by all the four target search tools used (RNA-hybrid, TargetSpy, PITA, Miranda)
3DE-miRs predicted to target the gene by three of the four target search tools used. 4Genbank reference number
Transcription factor binding motifs in the upstream genome sequences of DE miRNA genes
| miRNA gene | upstream TATA-box | ISRE-IRF1 M00972 | IRF1 M00747 | PU.1 | GAS | IRF3 M00772 | IRF8 M01665 | NF-kappaB M00051 | ETS2 M00340 | Genbank Accesion # |
|---|---|---|---|---|---|---|---|---|---|---|
| miR462a/731 cluster | 1 | 2 | 1 | 1 | 2 | 1 | 1 | - | - | gi|925216714:63629639-63631038 (NC_027314.1) |
| ssa-mir-462b | 1 | 2 | 1 | 1 | 1 | 2 | 1 | - | - | gi|925216718:28307432-28308831 (NC_027312.1) |
| ssa-mir-146a-1 | - | - | - | - | 3 | - | 1 | - | - | gi|925216706:4556929-4558189 (NC_027317.1) |
| ssa-mir-146a-2 | - | - | - | - | 2 | - | - | - | - | gi|925216783:47301787-47303047 (NC_027300.1) |
| ssa-mir-146b | - | 1 | 1 | - | 5 | - | 1 | - | - | gi|925216704:2641623-2642883 (NC_027318.1) |
| ssa-mir-146a-3 | - | - | 3 | - | 3 | - | - | - | - | gi|925216704:51691919-51693179 (NC_027318.1) |
| ssa-mir-21a-1 | 2 | - | - | - | 1 | - | 1 | - | - | gi|925216727:116610294-116611574 (NC_027308.1) |
| ssa-mir-21a-2 | 1 | - | - | - | 1 | - | 2 | - | - | gi|925216702:60966622-60967902 (NC_027319.1) |
| ssa-mir-21b-1 | 1 | - | - | - | 1 | - | 1 | - | - | gi|925216769:50774080-50775360 (NC_027303.1) |
| ssa-mir-21b-2 | - | - | 1 | - | 1 | 1 | 1 | - | - | gi|925216718:73813159-73814439 (NC_027312.1) |
| ssa-mir-1338 | - | - | 2 | - | 1 | - | 2 | - | - | gi|925216772:45802741-45804012 (NC_027302.1) |
| ssa-mir-155-1 | - | 1 | - | - | 6 | - | - | 1 | 1 | gi|925146043:6698-7958 (NW_012350889.1) |
| ssa-mir-92a-3 | - | - | - | - | 1 | - | - | - | - | gi|925125935:50220-51479 (NW_012343521.1) |
| ssa-mir-7132b-1 | 2 | - | - | 1 | 4 | - | - | - | - | gi|925216780:44866633-44867894 (NC_027301.1) |
| ssa-mir-7132b-2 | 3 | - | - | 1 | 1 | - | - | - | - | gi|925216720:24179665-24180926 (NC_027311.1) |
| ssa-mir-7132a-1 | - | - | 1 | 1 | 1 | - | 1 | - | - | gi|925216772:70457167-70458424 (NC_027302.1) |
| ssa-mir-7132a-2 | - | - | 1 | 1 | 1 | - | - | - | - | gi|925216757:28942285-28943542 (NC_027305.1) |
| ssa-mir-734 | - | - | - | - | - | - | - | - | - | gi|925216691:29709642-29710902 (NC_027324.1) |
| ssa-mir-181b | 1 | - | - | - | - | 1 | - | - | - | gi|925216772:43728947-43730207 (NC_027302.1) |
| ssa-mir-181c | 1 | - | - | - | 2 | - | - | - | - | gi|925216723:49524703-49525962 (NC_027310.1) |
| ssa-mir-2188-1 | - | - | - | - | - | - | - | - | - | gi|925216702:26812353-26813612 (NC_027319.1) |
| ssa-mir-2188-2 | - | - | - | - | - | - | - | - | - | gi|925216694:16936155-16937414 (NC_027323.1) |
| miR-223-1 | 1 | - | 1 | - | 4 | - | 1 | - | - | gi|925216769:43698893-43700211 (NC_027303) |
| miR-223-2 | - | - | 1 | - | 2 | 1 | 1 | - | - | gi|925216718:81008935-81010247 (NC_027312.1) |
Consensus sequences to each of the nine cis-elements are given in Additional file 4
Genbank accession # gives the complete genome sequences spanning the miRNA genes analysed